期刊
CURRENT VASCULAR PHARMACOLOGY
卷 13, 期 4, 页码 449-458出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570161112666141014145440
关键词
Combinational therapy; microparticles; vascular disease
资金
- National Institutes of Health (NIH) [HL098637]
- American Heart Association (AHA) [13POST14780018]
- National Natural Science Foundation of China (NSFC) [81270195, 81260060]
Vascular disease constitutes the leading health problem throughout the entire world. Current therapies for vascular disease mainly rely on comprehensive strategies including control of risk factors, vascular interventions and conventional supportive treatments. To improve the preventive and therapeutic efficacies of current approaches, novel combinational therapies are required. Microparticles (MPs) are small membrane vesicles derived from cells undergoing stress, activation or apoptosis. They carry the characteristics of their parent cells, enabling them to serve as potential biomarkers for various diseases. Of note, MPs also have been shown to mediate cell communications through transferring membrane proteins, phospholipids and RNAs from their parent cells to recipient cells. Recent novel approaches have started to reveal the functions of MPs. In this review, we summarize the general concepts and the latest research progress in MPs. And the potential of MPs as novel targets of combinational therapy for vascular disease will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据